U.S. Markets close in 2 hrs 8 mins
S&P 500
3,298.63+4.02(+0.12%)Nasdaq
10,913.75+10.95(+0.10%)Russell 2000
1,513.71+6.91(+0.46%)
TG Therapeutics, Inc. (TGTX)
NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
20.52-0.29 (-1.39%)
As of 1:51PM EDT. Market open.
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 20.81 |
| Open | 20.60 |
| Bid | 20.54 x 1000 |
| Ask | 20.56 x 800 |
| Day's Range | 19.81 - 20.64 |
| 52 Week Range | 4.95 - 24.76 |
| Volume | 677,918 |
| Avg. Volume | 2,250,053 |
| Market Cap | 2.354B |
| Beta (5Y Monthly) | 2.46 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.00 |
| Earnings Date | Aug 07, 2020 - Aug 11, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 39.33 |
- Zacks
TG Therapeutics (TGTX) Moves to Buy: Rationale Behind the Upgrade
TG Therapeutics (TGTX) has been upgraded to a Zacks Rank 2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks
Are You Looking for a Top Momentum Pick? Why TG Therapeutics (TGTX) is a Great Choice
Does TG Therapeutics (TGTX) have what it takes to be a top stock pick for momentum investors? Let's find out.
- Insider Monkey
Did Hedge Funds Make The Right Call On TG Therapeutics Inc (TGTX) ?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings. The 13F filings show the hedge funds' and successful investors' positions as of the end of the first quarter. You can find articles about an individual hedge fund's trades on numerous financial […]
© 2020 Verizon Media. All rights reserved.
